{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:52:15Z","timestamp":1787291535972,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,27]]},"DOI":"10.7759\/cureus.19078","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T14:32:48Z","timestamp":1635345168000},"source":"Crossref","is-referenced-by-count":9,"title":["A Clinical Review of the Psychiatric Sequelae of Primary Hyperparathyroidism"],"prefix":"10.7759","author":[{"given":"Ryan","family":"Serdenes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha","family":"Chandrasekhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser WD","year":"2009","unstructured":"Fraser WD. Hyperparathyroidism. Lancet. 2009, 374:145-158. 10.1016\/S0140-6736(09)60507-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650061409","article-title":"Epidemiology of primary hyperparathyroidism","volume":"6","author":"Melton LJ III","year":"1991","unstructured":"Melton LJ III. Epidemiology of primary hyperparathyroidism. J Bone Miner Res. 1991, 6:S25-S30. 10.1002\/jbmr.5650061409","journal-title":"J Bone Miner Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press DM","year":"2013","unstructured":"Press DM, Siperstein AE, Berber E, et al.. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery. 2013, 154:1232-1238. 10.1016\/j.surg.2013.06.051","journal-title":"Surgery"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/BF01655425","article-title":"Psychiatric morbidity in primary hyperparathyroidism","volume":"12","author":"Joborn C","year":"1988","unstructured":"Joborn C, Hetta J, Johansson H, Rastad J, Agren H, Akerstr\u00f6m G, Ljunghall S. Psychiatric morbidity in primary hyperparathyroidism. World J Surg. 1988, 12:476-480. 10.1007\/BF01655425","journal-title":"World J Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13081057","article-title":"Hypercalcemia and \"primary\" hyperparathyroidism during lithium therapy","volume":"172","author":"Shapiro HI","year":"2015","unstructured":"Shapiro HI, Davis KA. Hypercalcemia and \"primary\" hyperparathyroidism during lithium therapy. Am J Psychiatry. 2015, 172:12-15. 10.1176\/appi.ajp.2013.13081057","journal-title":"Am J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343540","article-title":"Coexistence of primary hyperparathyroidism and thyroid disease","volume":"22","author":"Regal M","year":"1999","unstructured":"Regal M, P\u00e1ramo C, Luna Cano R, P\u00e9rez M\u00e9ndez LF, Sierra JM, Rodr\u00edguez I, Garc\u00eda-Mayor RV. Coexistence of primary hyperparathyroidism and thyroid disease. J Endocrinol Invest. 1999, 22:191-197. 10.1007\/BF03343540","journal-title":"J Endocrinol Invest"},{"key":"ref7","article-title":"Epidemiology of primary hyperparathyroidism in Europe","volume":"17","author":"Adami S","year":"2002","unstructured":"Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002, 17:N18-N23.","journal-title":"J Bone Miner Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh MW","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC, et al.. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013, 98:1122-1129. 10.1210\/jc.2012-4022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler ML","year":"2015","unstructured":"Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ III, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015, 73:1-7. 10.1016\/j.bone.2014.12.003","journal-title":"Bone"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00912.x","article-title":"The effects of age and gender on parathyroid hormone dynamics","volume":"52","author":"Haden ST","year":"2000","unstructured":"Haden ST, Brown EM, Hurwitz S, Scott J, El-Hajj Fuleihan G. The effects of age and gender on parathyroid hormone dynamics. Clin Endocrinol (Oxf). 2000, 52:329-338. 10.1046\/j.1365-2265.2000.00912.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.5.3946","article-title":"Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study","volume":"82","author":"Khosla S","year":"1997","unstructured":"Khosla S, Atkinson EJ, Melton LJ III, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab. 1997, 82:1522-1527. 10.1210\/jcem.82.5.3946","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008121258","article-title":"Indirect regulation of PTH by estrogens may require FGF23","volume":"20","author":"Carrillo-L\u00f3pez N","year":"2009","unstructured":"Carrillo-L\u00f3pez N, Rom\u00e1n-Garc\u00eda P, Rodr\u00edguez-Rebollar A, Fern\u00e1ndez-Mart\u00edn JL, Naves-D\u00edaz M, Cannata-And\u00eda JB. Indirect regulation of PTH by estrogens may require FGF23. J Am Soc Nephrol. 2009, 20:2009-2017. 10.1681\/ASN.2008121258","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.48.3.265","article-title":"Mania in a case of hyperparathyroidism","volume":"48","author":"Brown SW","year":"2007","unstructured":"Brown SW, Vyas BV, Spiegel DR. Mania in a case of hyperparathyroidism. Psychosomatics. 2007, 48:265-268. 10.1176\/appi.psy.48.3.265","journal-title":"Psychosomatics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5479.85","article-title":"Catatonic stupor in elderly woman with hyperparathyroidism","volume":"1","author":"Hockaday TD","year":"1996","unstructured":"Hockaday TD, Keynes WM, McKenzie JK. Catatonic stupor in elderly woman with hyperparathyroidism. Br Med J. 1996, 1:85. 10.1136\/bmj.1.5479.85","journal-title":"Br Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1098-108x(199907)26:1<107::aid-eat15>3.0.co;2-u","article-title":"Complete recovery from intractable bulimia nervosa by the surgical cure of primary hyperparathyroidism","volume":"26","author":"Ozawa Y","year":"1999","unstructured":"Ozawa Y, Koyano H, Akama T. Complete recovery from intractable bulimia nervosa by the surgical cure of primary hyperparathyroidism. Int J Eat Disord. 1999, 26:107-110. 10.1002\/(sici)1098-108x(199907)26:1&lt;107::aid-eat15&gt;3.0.co;2-u","journal-title":"Int J Eat Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5858\/2009-0578-CCR.1","article-title":"Parathyroid pathology: hyperparathyroidism and parathyroid tumors","volume":"134","author":"Carlson D","year":"2010","unstructured":"Carlson D. Parathyroid pathology: hyperparathyroidism and parathyroid tumors. Arch Pathol Lab Med. 2010, 134:1639-1644. 10.5858\/2009-0578-CCR.1","journal-title":"Arch Pathol Lab Med"},{"key":"ref17","article-title":"Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy","volume":"35","author":"Brown GG","year":"1987","unstructured":"Brown GG, Preisman RC, Kleerekoper M. Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Med J. 1987, 35:211-215.","journal-title":"Henry Ford Hosp Med J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90085-6","article-title":"Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism","volume":"23","author":"Joborn C","year":"1988","unstructured":"Joborn C, Hetta J, Rastad J, Agren H, Akerstr\u00f6m G, Ljunghall S. Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiatry. 1988, 23:149-158. 10.1016\/0006-3223(88)90085-6","journal-title":"Biol Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(91)90017-n","article-title":"Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism","volume":"16","author":"Joborn C","year":"1991","unstructured":"Joborn C, Hetta J, Niklasson F, et al.. Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrinology. 1991, 16:311-322. 10.1016\/0306-4530(91)90017-n","journal-title":"Psychoneuroendocrinology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000186831","article-title":"Effect of chronic renal failure with and without secondary hyperparathyroidism on the activities of synaptosomal tyrosine hydroxylase and monoamine oxidase","volume":"61","author":"Islam A","year":"1992","unstructured":"Islam A, Smorgorzewski M, Zayed MA, Massry SG. Effect of chronic renal failure with and without secondary hyperparathyroidism on the activities of synaptosomal tyrosine hydroxylase and monoamine oxidase. Nephron. 1992, 61:32-36. 10.1159\/000186831","journal-title":"Nephron"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.217","article-title":"Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure","volume":"36","author":"Smogorzewski M","year":"1989","unstructured":"Smogorzewski M, Campese VM, Massry SG. Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure. Kidney Int. 1989, 36:458-465. 10.1038\/ki.1989.217","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(93)90041-e","article-title":"Parathyroid hormone-induced dopamine turnover in the rat medial basal hypothalamus","volume":"14","author":"Harvey S","year":"1993","unstructured":"Harvey S, Hayer S, Sloley BD. Parathyroid hormone-induced dopamine turnover in the rat medial basal hypothalamus. Peptides. 1993, 14:269-274. 10.1016\/0196-9781(93)90041-e","journal-title":"Peptides"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000045115","article-title":"Depression and secondary hyperparathyroidism in chronic renal failure","volume":"79","author":"Cengiz K","year":"1998","unstructured":"Cengiz K, Ozkan A. Depression and secondary hyperparathyroidism in chronic renal failure. Nephron. 1998, 79:508-509. 10.1159\/000045115","journal-title":"Nephron"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.5.508","article-title":"Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults","volume":"65","author":"Hoogendijk WJ","year":"2008","unstructured":"Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008, 65:508-512. 10.1001\/archpsyc.65.5.508","journal-title":"Arch Gen Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181f66720","article-title":"The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"253","author":"Roman SA","year":"2011","unstructured":"Roman SA, Sosa JA, Pietrzak RH, Snyder PJ, Thomas DC, Udelsman R, Mayes L. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg. 2011, 253:131-137. 10.1097\/SLA.0b013e3181f66720","journal-title":"Ann Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k06-152","article-title":"Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism","volume":"54","author":"Chiba Y","year":"2007","unstructured":"Chiba Y, Satoh K, Ueda S, Kanazawa N, Tamura Y, Horiuchi T. Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism. Endocr J. 2007, 54:379-383. 10.1507\/endocrj.k06-152","journal-title":"Endocr J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(98)00904-4","article-title":"Interleukin-2 and -6 induce behavioral-activating effects in mice","volume":"811","author":"Zalcman S","year":"1998","unstructured":"Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res. 1998, 811:111-121. 10.1016\/s0006-8993(98)00904-4","journal-title":"Brain Res"},{"key":"ref28","article-title":"Hyperparathyroidism","volume":"56","author":"Tonini G","year":"2004","unstructured":"Tonini G, Tat\u00f2 L, Rigon F, et al.. Hyperparathyroidism. Minerva Pediatr. 2004, 56:125-131.","journal-title":"Minerva Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen SA","year":"2016","unstructured":"Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016, 6:391-398. 10.5498\/wjp.v6.i4.391","journal-title":"World J Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.4.1.3","article-title":"The calcium second messenger system in bipolar disorders: data supporting new research directions","volume":"4","author":"Dubovsky SL","year":"1992","unstructured":"Dubovsky SL, Murphy J, Christiano J, Lee C. The calcium second messenger system in bipolar disorders: data supporting new research directions. J Neuropsychiatry Clin Neurosci. 1992, 4:3-14. 10.1176\/jnp.4.1.3","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199509000-00017","article-title":"Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study","volume":"222","author":"Chan AK","year":"1995","unstructured":"Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg. 1995, 222:402-412. 10.1097\/00000658-199509000-00017","journal-title":"Ann Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2013.01.017","article-title":"Ionized vs serum calcium in the diagnosis and management of primary hyperparathyroidism: which is superior?","volume":"205","author":"Tee MC","year":"2013","unstructured":"Tee MC, Holmes DT, Wiseman SM. Ionized vs serum calcium in the diagnosis and management of primary hyperparathyroidism: which is superior?. Am J Surg. 2013, 205:591-596. 10.1016\/j.amjsurg.2013.01.017","journal-title":"Am J Surg"},{"key":"ref33","article-title":"Diagnostic approach to hypercalcemia","author":"Shane E","year":"2020","unstructured":"Shane E. Diagnostic approach to hypercalcemia. UpToDate. Rosen CJ, Mulder JE (ed): UpToDate, Waltham, MA; 2020."},{"key":"ref34","article-title":"Primary hyperparathyroidism: management","author":"Silverberg S","year":"2019","unstructured":"Silverberg S, Fuleihan GE. Primary hyperparathyroidism: management. UpToDate. Rosen CJ, Mulder JE (ed): UpToDate, Waltham, MA; 2019."},{"key":"ref35","article-title":"Primary hyperparathyroidism: diagnosis, differential diagnosis, and evaluation","author":"Fuleihan GE","year":"2020","unstructured":"Fuleihan GE, Silverberg S. Primary hyperparathyroidism: diagnosis, differential diagnosis, and evaluation. UpToDate. Rosen CJ, Mulder JE (ed): UpToDate, Waltham, MA; 2020."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic primary hyperparathyroidism","volume":"16","author":"Cusano NE","year":"2013","unstructured":"Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom. 2013, 16:33-39. 10.1016\/j.jocd.2012.12.001","journal-title":"J Clin Densitom"},{"key":"ref37","article-title":"Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism","author":"Yip L","year":"2020","unstructured":"Yip L, Silverberg SJ, Fuleihan GE. Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism. UpToDate. Carty SE, Rosen CJ, Chen W (ed): UpToDate, Waltham, MA; 2020."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.145.5.477","article-title":"Hyperparathyroidism and paranoid psychosis. Case report and review of the literature","volume":"145","author":"Alarc\u00f3n RD","year":"1984","unstructured":"Alarc\u00f3n RD, Franceschini JA. Hyperparathyroidism and paranoid psychosis. Case report and review of the literature. Br J Psychiatry. 1984, 145:477-486. 10.1192\/bjp.145.5.477","journal-title":"Br J Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.10016","article-title":"Gabapentin: a novel analgesic targeting voltage\u2010gated calcium channels","volume":"54","author":"Sutton KG","year":"2001","unstructured":"Sutton KG, Snutch TP. Gabapentin: a novel analgesic targeting voltage\u2010gated calcium channels. Drug Dev Res. 2001, 54:167-172. 10.1002\/ddr.10016","journal-title":"Drug Dev Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.02204.x","article-title":"Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine","volume":"45","author":"Pisani A","year":"2004","unstructured":"Pisani A, Bonsi P, Martella G, et al.. Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia. 2004, 45:719-728. 10.1111\/j.0013-9580.2004.02204.x","journal-title":"Epilepsia"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16111226","article-title":"Psychiatric complications of primary hyperparathyroidism and mild hypercalcemia","volume":"174","author":"Parks KA","year":"2017","unstructured":"Parks KA, Parks CG, Onwuameze OE, Shrestha S. Psychiatric complications of primary hyperparathyroidism and mild hypercalcemia. Am J Psychiatry. 2017, 174:620-622. 10.1176\/appi.ajp.2017.16111226","journal-title":"Am J Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian JP","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014, 99:3561-3569. 10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2020.06.006","article-title":"Neuropsychologic changes in primary hyperparathyroidism after parathyroidectomy from a dual-institution prospective study","volume":"169","author":"Liu JY","year":"2021","unstructured":"Liu JY, Peine BS, Mlaver E, et al.. Neuropsychologic changes in primary hyperparathyroidism after parathyroidectomy from a dual-institution prospective study. Surgery. 2021, 169:114-119. 10.1016\/j.surg.2020.06.006","journal-title":"Surgery"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67504-a-clinical-review-of-the-psychiatric-sequelae-of-primary-hyperparathyroidism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:49Z","timestamp":1707507169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67504-a-clinical-review-of-the-psychiatric-sequelae-of-primary-hyperparathyroidism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.19078","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,27]]}}}